Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer
Nancy Y. Lee, Luc G.T. Morris, Maximilian Diehn
Abstract
This Viewpoint evaluates the use of tumor tissue–modified human papillomavirus (HPV) DNA in identifying minimal residual disease.
Topics & Concepts
MedicineHuman papillomavirusCancerMinimal residual diseaseCirculating tumor DNAPapillomaviridaeDNAOncologyInternal medicinePathologyCancer researchCervical cancerGeneticsLeukemiaBiologyHead and Neck Cancer StudiesLung Cancer Treatments and MutationsEsophageal Cancer Research and Treatment